Pasireotide Extended-Release Injection and Ultravate
Determining the interaction of Pasireotide Extended-Release Injection and Ultravate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: halobetasol topical
Brand name: Bryhali, Ultravate, Ultravate X Cream, Ultravate X Ointment, Lexette
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Ultravate (Halobetasol Cream and Ointment)
- Pasireotide Extended-Release Injection-Ultravate (Halobetasol Lotion)
- Pasireotide Extended-Release Injection-Ultravate Cream
- Pasireotide Extended-Release Injection-Ultravate Lotion
- Pasireotide Extended-Release Injection-Ultravate X
- Pasireotide Extended-Release Injection-Ultravate X Cream
- Ultravate-Pasireotide Injection
- Ultravate-Pasireotide Subcutaneous
- Ultravate-Patanase
- Ultravate-Patiromer
- Ultravate-Patiromer Sorbitex Calcium
- Ultravate-Pavacot